Camurus
567
SEK
+0,62 %
CAMX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
9 investorer følger denne virksomhed
+0,62%
-1,05%
-10,07%
-1,39%
+5,39%
+8,83%
+296,5%
+568,63%
+838,34%
Camurus operates in biotechnology. The company runs as a research-based pharmaceutical company and develops and distributes products for the treatment of severe and chronic diseases. Diseases treated with the company's products include, for example, cancer, endocrine disorders, and patients with opioid dependence. Camurus runs development projects under its own auspices and in partnership with international pharmaceutical companies. The company is headquartered in Lund.
Læs mereMarkedsværdi
33,38 mia. SEK
Aktieomsætning
18,43 mio. SEK
Omsætning
1,72 mia.
EBIT %
30,63 %
P/E
72,88
Udbytteafkast, %
-
Finanskalender
13.2
2025
Årsrapport '24
15.5
2025
Delårsrapport Q1'25
27.5
2025
Generalforsamling '24
ViserAlle indholdstyper
Camurus AB: Camurus to present at Jefferies London Healtcare Conference
Camurus, Audiocast with teleconference, Q3'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools